Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Genetics

  Free Subscription


Articles published in Br J Cancer

Retrieve available abstracts of 33 articles:
HTML format



Single Articles


    November 2022
  1. NEUMANN O, Burn TC, Allgauer M, Ball M, et al
    Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing.
    Br J Cancer. 2022;127:1540-1549.
    PubMed     Abstract available


  2. HILTBRUNNER S, Fleischmann Z, Sokol ES, Zoche M, et al
    Genomic landscape of pleural and peritoneal mesothelioma tumours.
    Br J Cancer. 2022;127:1997-2005.
    PubMed     Abstract available


    October 2022
  3. JAN YH, Tan KT, Chen SJ, Yip TTC, et al
    Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing.
    Br J Cancer. 2022;127:1304-1311.
    PubMed     Abstract available


    September 2022
  4. LI H, Sun Z, Xiao R, Qi Q, et al
    Stepwise evolutionary genomics of early-stage lung adenocarcinoma manifesting as pure, heterogeneous and part-solid ground-glass nodules.
    Br J Cancer. 2022;127:747-756.
    PubMed     Abstract available


  5. PRUIS MA, Groenendijk FH, Badloe KS, van Puffelen A, et al
    Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing.
    Br J Cancer. 2022;127:776-783.
    PubMed     Abstract available


    August 2022
  6. JUNG S, Armstrong E, Wei AZ, Ye F, et al
    Clinical and genomic correlates of imatinib response in melanomas with KIT alterations.
    Br J Cancer. 2022 Aug 23. pii: 10.1038/s41416-022-01942.
    PubMed     Abstract available


  7. HSIEH CC, Hsu SH, Lin CY, Liaw HJ, et al
    CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer.
    Br J Cancer. 2022 Aug 23. pii: 10.1038/s41416-022-01946.
    PubMed     Abstract available


  8. INGEBRIKTSEN LM, Finne K, Akslen LA, Wik E, et al
    A novel age-related gene expression signature associates with proliferation and disease progression in breast cancer.
    Br J Cancer. 2022 Aug 23. pii: 10.1038/s41416-022-01953.
    PubMed     Abstract available


    July 2022
  9. ROBINSON N, Casement J, Gunter MJ, Huybrechts I, et al
    Anti-cancer therapy is associated with long-term epigenomic changes in childhood cancer survivors.
    Br J Cancer. 2022;127:288-300.
    PubMed     Abstract available


  10. GLEWIS S, Alexander M, Khabib MNH, Brennan A, et al
    A systematic review and meta-analysis of toxicity and treatment outcomes with pharmacogenetic-guided dosing compared to standard of care BSA-based fluoropyrimidine dosing.
    Br J Cancer. 2022;127:126-136.
    PubMed     Abstract available


    June 2022
  11. CATANZARO D, Milani G, Bozza A, Bernardi M, et al
    Selective cell cycle arrest in glioblastoma cell lines by quantum molecular resonance alone or in combination with temozolomide.
    Br J Cancer. 2022 Jun 17. pii: 10.1038/s41416-022-01865.
    PubMed     Abstract available


    March 2022
  12. BOLGER JC, Donohoe CL, Lowery M, Reynolds JV, et al
    Advances in the curative management of oesophageal cancer.
    Br J Cancer. 2022;126:706-717.
    PubMed     Abstract available


    January 2022
  13. LAL N, Chan DKH, Ng ME, Vermeulen L, et al
    Primary tumour immune response and lymph node yields in colon cancer.
    Br J Cancer. 2022 Jan 18. pii: 10.1038/s41416-022-01700.
    PubMed     Abstract available


  14. SUN J, Yan C, Xu D, Zhang Z, et al
    Immuno-genomic characterisation of high-grade serous ovarian cancer reveals immune evasion mechanisms and identifies an immunological subtype with a favourable prognosis and improved therapeutic efficacy.
    Br J Cancer. 2022 Jan 11. pii: 10.1038/s41416-021-01692.
    PubMed     Abstract available


    December 2021
  15. ZHANG X, Li X, He Y, Law PJ, et al
    Phenome-wide association study (PheWAS) of colorectal cancer risk SNP effects on health outcomes in UK Biobank.
    Br J Cancer. 2021 Dec 15. pii: 10.1038/s41416-021-01655.
    PubMed     Abstract available


    November 2021
  16. ROMUALDO CARDOSO S, Gillespie A, Haider S, Fletcher O, et al
    Functional annotation of breast cancer risk loci: current progress and future directions.
    Br J Cancer. 2021 Nov 5. pii: 10.1038/s41416-021-01612.
    PubMed     Abstract available


  17. HAKOZAKI K, Tanaka N, Takamatsu K, Takahashi R, et al
    Landscape of prognostic signatures and immunogenomics of the AXL/GAS6 axis in renal cell carcinoma.
    Br J Cancer. 2021;125:1533-1543.
    PubMed     Abstract available


    September 2021
  18. CHEN D, Bao X, Zhang R, Ding Y, et al
    Depiction of the genomic and genetic landscape identifies CCL5 as a protective factor in colorectal neuroendocrine carcinoma.
    Br J Cancer. 2021;125:994-1002.
    PubMed     Abstract available


  19. CRISPIN-ORTUZAR M, Sala E
    Precision radiogenomics: fusion biopsies to target tumour habitats in vivo.
    Br J Cancer. 2021;125:778-779.
    PubMed     Abstract available


    August 2021
  20. GEVAERT O
    Meta-learning reduces the amount of data needed to build AI models in oncology.
    Br J Cancer. 2021;125:309-310.
    PubMed     Abstract available


    July 2021
  21. LEI JT, Zhang B
    Proteogenomics drives therapeutic hypothesis generation for precision oncology.
    Br J Cancer. 2021;125:1-3.
    PubMed     Abstract available


    June 2021
  22. LEE KH, Chen WS, Jiang JK, Yang SH, et al
    The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon.
    Br J Cancer. 2021 Jun 29. pii: 10.1038/s41416-021-01470.
    PubMed     Abstract available


    May 2021
  23. SINGH G, Manjila S, Sakla N, True A, et al
    Radiomics and radiogenomics in gliomas: a contemporary update.
    Br J Cancer. 2021 May 6. pii: 10.1038/s41416-021-01387.
    PubMed     Abstract available


    February 2021
  24. ROSENTHAL R, Swanton C, McGranahan N
    Understanding the impact of immune-mediated selection on lung cancer evolution.
    Br J Cancer. 2021 Feb 24. pii: 10.1038/s41416-020-01232.
    PubMed     Abstract available


    January 2021
  25. BARROW TM, Nakjang S, Lafta F, Bilotkach K, et al
    Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia.
    Br J Cancer. 2021;124:474-483.
    PubMed     Abstract available


    October 2020
  26. CHA PH, Hwang JH, Kwak DK, Koh E, et al
    APC loss induces Warburg effect via increased PKM2 transcription in colorectal cancer.
    Br J Cancer. 2020 Oct 19. pii: 10.1038/s41416-020-01118.
    PubMed     Abstract available


    July 2020
  27. HORNIGOLD N, Dunn KR, Craven RA, Zougman A, et al
    Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion.
    Br J Cancer. 2020;123:137-147.
    PubMed     Abstract available


    May 2020
  28. FORD CE, Werner B, Hacker NF, Warton K, et al
    The untapped potential of ascites in ovarian cancer research and treatment.
    Br J Cancer. 2020 May 8. pii: 10.1038/s41416-020-0875.
    PubMed     Abstract available


    March 2020
  29. LUCA BA, Moulton V, Ellis C, Edwards DR, et al
    A novel stratification framework for predicting outcome in patients with prostate cancer.
    Br J Cancer. 2020 Mar 20. pii: 10.1038/s41416-020-0799.
    PubMed     Abstract available


  30. POWLEY IR, Patel M, Miles G, Pringle H, et al
    Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery.
    Br J Cancer. 2020;122:735-744.
    PubMed     Abstract available


    February 2020
  31. NIEGISCH G
    Predicting immune checkpoint inhibitor response in urothelial carcinoma: another step in personalised medicine?
    Br J Cancer. 2020;122:453-454.
    PubMed     Abstract available


  32. VISSIO E, Metovic J, Osella-Abate S, Bertero L, et al
    Integration of Ki-67 index into AJCC 2018 staging provides additional prognostic information in breast tumours candidate for genomic profiling.
    Br J Cancer. 2020;122:382-387.
    PubMed     Abstract available


    January 2020
  33. WHITWELL HJ, Worthington J, Blyuss O, Gentry-Maharaj A, et al
    Improved early detection of ovarian cancer using longitudinal multimarker models.
    Br J Cancer. 2020 Jan 15. pii: 10.1038/s41416-019-0718.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Genetics is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: